| Primary |
| Product Used For Unknown Indication |
53.2% |
| Epilepsy |
19.1% |
| Convulsion |
7.9% |
| Lennox-gastaut Syndrome |
6.2% |
| Infantile Spasms |
4.9% |
| Grand Mal Convulsion |
1.1% |
| Partial Seizures |
1.0% |
| Complex Partial Seizures |
0.9% |
| Maternal Exposure Timing Unspecified |
0.9% |
| Lennox--gastaut Syndrome |
0.6% |
| Anxiety |
0.6% |
| Intentional Overdose |
0.6% |
| Status Epilepticus |
0.6% |
| Depression |
0.5% |
| Myoclonic Epilepsy |
0.5% |
| Temporal Lobe Epilepsy |
0.4% |
| Post-anoxic Myoclonus |
0.3% |
| Asthma |
0.2% |
| Atonic Seizures |
0.2% |
| Foetal Exposure Timing Unspecified |
0.2% |
|
| Convulsion |
18.4% |
| Somnolence |
15.5% |
| Aggression |
9.4% |
| Drug Ineffective |
7.1% |
| Sedation |
7.1% |
| Urinary Retention |
6.5% |
| Weight Increased |
6.5% |
| Irritability |
3.2% |
| Dizziness |
2.9% |
| Rash |
2.9% |
| Insomnia |
2.6% |
| Abnormal Behaviour |
2.3% |
| Status Epilepticus |
2.3% |
| Tremor |
2.3% |
| Urticaria |
2.3% |
| Agitation |
1.9% |
| Suicidal Ideation |
1.9% |
| Therapeutic Response Decreased |
1.9% |
| Drooling |
1.6% |
| Lethargy |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
52.7% |
| Convulsion |
14.3% |
| Epilepsy |
13.7% |
| Lennox-gastaut Syndrome |
7.3% |
| Grand Mal Convulsion |
2.4% |
| Complex Partial Seizures |
1.7% |
| Anxiety |
1.5% |
| Depression |
1.0% |
| Partial Seizures |
1.0% |
| Pruritus |
0.9% |
| Headache |
0.7% |
| Constipation |
0.6% |
| Temporal Lobe Epilepsy |
0.5% |
| Atonic Seizures |
0.4% |
| Infantile Spasms |
0.4% |
| Hypothyroidism |
0.3% |
| Myoclonic Epilepsy |
0.3% |
| Aggression |
0.2% |
| Astrocytoma |
0.2% |
| Gastrooesophageal Reflux Disease |
0.2% |
|
| Somnolence |
17.5% |
| Weight Increased |
11.7% |
| Convulsion |
9.7% |
| Weight Bearing Difficulty |
5.8% |
| Dizziness |
5.2% |
| Urinary Retention |
4.5% |
| Urticaria |
4.5% |
| Rash |
3.9% |
| Sedation |
3.9% |
| Upper Respiratory Tract Infection |
3.9% |
| Hypoventilation |
3.2% |
| Suicidal Ideation |
3.2% |
| Tenderness |
3.2% |
| Vertigo |
3.2% |
| Vomiting |
3.2% |
| Aggression |
2.6% |
| Drug Ineffective |
2.6% |
| Feeling Abnormal |
2.6% |
| Irritability |
2.6% |
| Memory Impairment |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
56.5% |
| Epilepsy |
12.1% |
| Infantile Spasms |
9.5% |
| Convulsion |
8.5% |
| Complex Partial Seizures |
3.2% |
| Hypertension |
1.4% |
| Tuberous Sclerosis |
1.2% |
| Acquired Epileptic Aphasia |
0.8% |
| Anxiety |
0.8% |
| Partial Seizures |
0.8% |
| Quadriplegia |
0.8% |
| Seizure |
0.8% |
| Dyspnoea |
0.6% |
| Nasal Congestion |
0.6% |
| Wheezing |
0.6% |
| Emphysema |
0.4% |
| Gastrooesophageal Reflux Disease |
0.4% |
| Grand Mal Convulsion |
0.4% |
| Hypersensitivity |
0.4% |
| Respiratory Tract Congestion |
0.4% |
|
| Convulsion |
21.3% |
| Drug Ineffective |
14.7% |
| Pneumonia |
8.0% |
| Product Substitution Issue |
5.3% |
| Pyrexia |
5.3% |
| Death |
4.0% |
| Hypoxia |
4.0% |
| Screaming |
4.0% |
| Tonic Convulsion |
4.0% |
| Tremor |
4.0% |
| Muscular Weakness |
2.7% |
| Osteitis Deformans |
2.7% |
| Sepsis |
2.7% |
| Thinking Abnormal |
2.7% |
| Unevaluable Event |
2.7% |
| Upper Respiratory Tract Infection |
2.7% |
| Urinary Tract Infection |
2.7% |
| Visual Field Defect |
2.7% |
| Vomiting |
2.7% |
| Chest Pain |
1.3% |
|
| Interacting |
| Convulsion |
54.5% |
| Epilepsy |
27.3% |
| Product Used For Unknown Indication |
18.2% |
|
| Sedation |
60.0% |
| Drug Interaction |
20.0% |
| Somnolence |
20.0% |
|
